XML 35 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3
Segment and Related Information
 9 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
Segment and Related Information
(15) SEGMENT AND RELATED INFORMATION

The Company’s business units have been aligned with how the Chief Operating Decision Maker (“CODM”) reviews performance and makes decisions in managing the Company. The business units have been aggregated into two reportable segments: (i) diagnostics and (ii) other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual’s risk for developing disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology. The prior periods presented have been restated to conform to the current presentation.

Segment revenue and operating income (loss) were as follows during the periods presented:

 

     Diagnostics      Other      Total  

Three months ended March 31, 2016

         

Revenues

    $ 177.4       $ 13.1       $ 190.5   

Depreciation and amortization

      5.4         1.2         6.6   

Segment operating income (loss)

      59.2         (16.6 )       42.6   

Three months ended March 31, 2015

         

Revenues

    $ 173.0       $ 7.0       $ 180.0   

Depreciation and amortization

      5.2         1.2         6.4   

Segment operating income (loss)

      55.2         (19.5 )       35.7   

Nine months ended March 31, 2016

         

Revenues

    $ 532.0       $ 35.4       $ 567.4   

Depreciation and amortization

      16.2         3.8         20.0   

Segment operating income (loss)

      186.3         (55.1 )       131.2   

Nine months ended March 31, 2015

         

Revenues

    $ 516.6       $ 16.6       $ 533.2   

Depreciation and amortization

      15.2         3.2         18.4   

Segment operating income (loss)

      159.3         (61.3 )       98.0   

 

     Three months ended
March 31,		      Nine months ended
March 31,		  
     2016      2015      2016      2015  

Total operating income for reportable segments

    $ 42.6       $ 35.7       $ 131.2       $ 98.0   

Unallocated amounts:

            

Interest income

      0.3         0.1         0.5         0.3   

Other

      0.2         (0.3 )       —           1.1   
  

 

 

     

 

 

     

 

 

     

 

 

  

Income from operations before income taxes

      43.1         35.5         131.7         99.4   
  

 

 

     

 

 

     

 

 

     

 

 

  

Income tax provision

      10.5         14.1         42.1         37.9   
  

 

 

     

 

 

     

 

 

     

 

 

  

Net income

    $ 32.6       $ 21.4       $ 89.6       $ 61.5